These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8814056)

  • 1. Monitoring collagen degradation in patients with arthritis. The search for suitable surrogates.
    Greenwald RA
    Arthritis Rheum; 1996 Sep; 39(9):1455-65. PubMed ID: 8814056
    [No Abstract]   [Full Text] [Related]  

  • 2. Diurnal variations in serum and urine markers of type I and type III collagen turnover in children.
    Wolthers OD; Heuck C; Heickendorff L
    Clin Chem; 2001 Sep; 47(9):1721-2. PubMed ID: 11514416
    [No Abstract]   [Full Text] [Related]  

  • 3. Urine levels of type 1 collagen cross-linked N-telopeptides and deoxypyridinoline correlate with disease activity in rheumatoid arthritis.
    al-Awadhi AM; Olusi SO; al-Zaid NS; Prabha K; al-Jarallah KH; Ahmed AH; al-Salem I; Sedeqi H; Atteyah Y
    Clin Exp Rheumatol; 1998; 16(5):569-72. PubMed ID: 9779304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross sectional analysis of 5 different markers of collagen degradation in rheumatoid arthritis.
    St Clair EW; Moak SA; Wilkinson WE; Sanders L; Lang T; Greenwald RA
    J Rheumatol; 1998 Aug; 25(8):1472-9. PubMed ID: 9712086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of markers of bone resorption are moderately increased in patients with inactive rheumatoid arthritis.
    Molenaar ET; Lems WF; Dijkmans BA; de Koning MH; van de Stadt RJ; Voskuyl AE
    Rheumatology (Oxford); 2000 Jul; 39(7):742-4. PubMed ID: 10908692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N; Juillet F; Garnero P
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of free and peptide bound collagen crosslink excretion in different skeletal diseases.
    Müller A; Jakob K; Hein GE
    Ann Rheum Dis; 2003 Jan; 62(1):65-7. PubMed ID: 12480673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis.
    Astbury C; Bird HA; McLaren AM; Robins SP
    Br J Rheumatol; 1994 Jan; 33(1):11-5. PubMed ID: 8162449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of collagen degradation products in human urine in osteoarthrosis.
    Macek J; Adam M
    Z Rheumatol; 1987; 46(5):237-40. PubMed ID: 3425008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of free and peptide-bound pyridinoline cross-links excretion in rheumatoid arthritis and osteoarthritis.
    Takahashi M; Suzuki M; Naitou K; Miyamoto S; Kushida K
    Rheumatology (Oxford); 1999 Feb; 38(2):133-8. PubMed ID: 10342625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telopeptides as markers of bone turnover in rheumatoid arthritis and osteoarthritis.
    Wong PK; Young L; Vaile JH; Tan L; Bertouch JV; Bleasel JF; White C
    Intern Med J; 2004; 34(9-10):539-44. PubMed ID: 15482266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of the cross linking compound, pyridinoline, in urine as an index of collagen degradation in joint disease.
    Robins SP; Stewart P; Astbury C; Bird HA
    Ann Rheum Dis; 1986 Dec; 45(12):969-73. PubMed ID: 3813668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis.
    Landewé RB; Geusens P; van der Heijde DM; Boers M; van der Linden SJ; Garnero P
    Ann Rheum Dis; 2006 Jan; 65(1):40-4. PubMed ID: 16126801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receiver operating characteristic analysis of urinary pyridinium cross-links in arthritis.
    Takahashi M; Kushida K; Inoue T
    Br J Rheumatol; 1995 Aug; 34(8):792-3. PubMed ID: 7551670
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
    Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
    J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in urinary excretion of helical peptide during therapy for osteoporosis in older adults.
    Taxel P; Fall PM; Prestwood KM; Dulipsingh L; Dauser D; Ohannessian C; Raisz LG
    Clin Chem; 2004 Apr; 50(4):747-50. PubMed ID: 15044330
    [No Abstract]   [Full Text] [Related]  

  • 17. Dupuytren's disease in type I diabetic subjects: investigation of biochemical markers of type III and I collagen.
    Arkkila PE; Koskinen PJ; Kantola IM; Rönnemaa T; Seppänen E; Viikari JS
    Clin Exp Rheumatol; 2000; 18(2):215-9. PubMed ID: 10812494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation.
    Nishi Y; Atley L; Eyre DE; Edelson JG; Superti-Furga A; Yasuda T; Desnick RJ; Gelb BD
    J Bone Miner Res; 1999 Nov; 14(11):1902-8. PubMed ID: 10571690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effect of nimesulide and ibuprofen on the urinary levels of collagen type II C-telopeptide degradation products and on the serum levels of hyaluronan and matrix metalloproteinases-3 and -13 in patients with flare-up of osteoarthritis.
    Manicourt DH; Bevilacqua M; Righini V; Famaey JP; Devogelaer JP
    Drugs R D; 2005; 6(5):261-71. PubMed ID: 16128596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis.
    Landewé R; Geusens P; Boers M; van der Heijde D; Lems W; te Koppele J; van der Linden S; Garnero P
    Arthritis Rheum; 2004 May; 50(5):1390-9. PubMed ID: 15146408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.